Siloam International Hospitals Tbk Pt operates within the General medical & surgical hospitals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Siloam International Hospitals Tbk Pt with three other
health care providers in Asia:
Raffles Medical Group Limited
sales of 489.14 million Singapore Dollars [US$345.43 million]
of which 59%
was Hospital Services),
Yihua Healthcare Co Ltd
(2.20 billion Chinese Renmimbi [US$308.89 million]
of which 87%
was Medical business), and
Samitivej Public Company Limited
based in THAILAND
(11.75 billion Thai Bahts [US$368.52 million]
of which 100%
During the year ended December of 2018, sales at
Siloam International Hospitals Tbk Pt were 5.96 trillion Indonesian Rupiahs (US$404.40 million).
a very small
increase of 2.0%
versus 2017, when the company's sales were 5.85 trillion Indonesian Rupiahs .
This was the fifth consecutive year of sales increases at Siloam International Hospitals Tbk Pt
(and since 2013, sales have increased a total of 138%).
Sales of Sh Makassar saw an increase
that was more than double the company's growth rate: sales were up
10.0% in 2018, from
297.33 billion Indonesian Rupiahs to 327.10 billion Indonesian Rupiahs .
Siloam International Hospitals Tbk Pt also saw significant increases in sales in
Others (up 8.1% to 2.13 trillion Indonesian Rupiahs )
Sh Lippo Vilage (up 4.0% to 867.33 billion Indonesian Rupiahs )
Mrccc (up 4.7% to 614.46 billion Indonesian Rupiahs )
Sh Surabaya (up 7.2% to 409.78 billion Indonesian Rupiahs )
Not all segments of Siloam International Hospitals Tbk Pt experienced an increase in sales in 2018:
sales of Sh Denpasar fell 1.1% to 316.92 billion Indonesian Rupiahs .